Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu, Estonia.
Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland.
Curr Opin Crit Care. 2021 Apr 1;27(2):183-192. doi: 10.1097/MCC.0000000000000802.
To summarize current evidence on acute mesenteric ischemia (AMI) in critically ill patients, addressing pathophysiology, definition, diagnosis and management.
A few recent studies showed that a multidiscipliary approach in specialized centers can improve the outcome of AMI. Such approach incorporates current knowledge in pathophysiology, early diagnosis with triphasic computed tomography (CT)-angiography, immediate endovascular or surgical restoration of mesenteric perfusion, and damage control surgery if transmural bowel infarction is present. No specific biomarkers are available to detect early mucosal injury in clinical setting. Nonocclusive mesenteric ischemia presents particular challenges, as the diagnosis based on CT-findings as well as vascular management is more difficult; some recent evidence suggests a possible role of potentially treatable stenosis of superior mesenteric artery and beneficial effect of vasodilator therapy (intravenous or local intra-arterial). Medical management of AMI is supportive, including aiming of euvolemia and balanced systemic oxygen demand/delivery. Enteral nutrition should be withheld during ongoing ischemia-reperfusion injury and be started at low rate after revascularization of the (remaining) bowel is convincingly achieved.
Clinical suspicion leading to tri-phasic CT-angiography is a mainstay for diagnosis. Diagnosis of nonocclusive mesenteric ischemia and early intestinal injury remains challenging. Multidisciplinary team effort may improve the outcome of AMI.
总结目前关于危重病患者急性肠系膜缺血(AMI)的证据,重点介绍其病理生理学、定义、诊断和治疗。
最近的一些研究表明,在专门中心采用多学科方法可以改善 AMI 的预后。这种方法结合了当前对病理生理学的认识、使用三时相 CT 血管造影术进行早期诊断、立即进行血管内或手术恢复肠系膜灌注,如果存在透壁肠梗死则采用损伤控制手术。目前尚无特定的生物标志物可用于在临床环境中检测早期黏膜损伤。非闭塞性肠系膜缺血带来了特殊的挑战,因为基于 CT 发现和血管管理的诊断更加困难;最近的一些证据表明,肠系膜上动脉潜在可治疗性狭窄可能具有一定作用,血管扩张剂治疗(静脉内或局部动脉内)可能有益。AMI 的内科治疗是支持性的,包括保持血容量正常和平衡全身氧需求/输送。在持续的缺血再灌注损伤期间应暂停肠内营养,并在(剩余)肠的再血管化后以较低的速度开始。
临床怀疑导致三时相 CT 血管造影是诊断的主要依据。非闭塞性肠系膜缺血和早期肠损伤的诊断仍然具有挑战性。多学科团队的努力可能会改善 AMI 的预后。